Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 7, 2008, Pages 1184-1188

  Marcondes, José A M ^a,d   Curi, Daniela D G ^b   Matsuzaki, Cezar N ^c   Barcellos, Cristiano R G ^a   Rocha, Michelle P ^a   Hayashida, Sylvia A Y ^b   Baracat, Edmund C ^b  

^a Endocrine Unit   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Nipo Brasileiro de São Paulo   (Brazil)

^d NONE   (Brazil)

Author keywords

Adrenal incidentaloma; Hirsutism; Menopause; Ovarian hyperthecosis

Indexed keywords

DRUG DERIVATIVE; GONADORELIN; TESTOSTERONE;

ADENOMA; ADRENAL TUMOR; ARTICLE; BLOOD; CASE REPORT; FEMALE; HIRSUTISM; HUMAN; MIDDLE AGED; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; POSTMENOPAUSE;

ADENOMA; ADRENAL GLAND NEOPLASMS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HIRSUTISM; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; TESTOSTERONE;

EID: 58149197154     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000700016     Document Type: Article

References (19)

1. Rosenfield RL. Pilosebaceous physiology in relation to hirsutism and acne. J Clin Endocrinol Metab. 1986;15:341-62.
2. Khan CR, Flier JS, Bas RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med. 1976;294:739-45.
3. Goldman JM, Kapadia JL. Virilization in a postmenopausal woman dueto ovarian stromal hyperthecosis. Postgrad Med J. 1991;67:304-9.
4. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-7.
5. Bachega TA, Billerbeck AE, Madureira G, Marcondes JA, Longui CA, Leite MV, et al. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1998;83:4416-9.
6. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004;25:309-40.
7. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab. 1997;82:1317-24.
8. Wajchenberg BL, Albergaria MAP, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000;88:711-36.
9. Dicker D, Dekel A, Feldberg D, Goldman JA, Kessler E. Bilateral sertoli-leydig cell tumor with heterologous elements: report of an unusual case and review of the literature. Eur J Obstet Gynecol Reprod Biol. 1986;22:175-81.
10. Henriksen HM, Fischer S, Guttorm E. Bilateral ovarian lipid cell hyperplasia in a young hirsute patient, Int J Gynaecol Obstet. 1981:19467-72.
11. Krug E, Berga SL. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol. 2002;99:893-7
12. Farber M, Madanes A, O'Briain DS, Millan VG, Turksoy RN, Rule AH. Asymmetric hyperthecosis ovari. Obstet Gynecol. 1981;57:521-5.
13. Werk Jr EE, Sholiton LE, Kalejs L. Testosterone-secreting adrenal adenoma under gonadotropin control. N Engl J Med. 1973;289:767-70.
14. Marcondes JA, Nery M, Mendonca BB, Hayashida SA, Halbe HW, Carvalho FM, et al. A virilizing Leydig cell tumor of the ovary associated with stromal hyperplasia under gonadotropin control. J Endocrinol Invest. 1997;20:685-9.
15. Barth JH, Jenkins M, Belchetz PE. Ovarian hyperthecosis, diabetes, and hirsutism in post-menopausal women. Clin Endocrinol (Oxf). 1997;46:123-8.
16. Steingold KA, Judd HL, Nieberg RK, Lu JK, Chang RJ. Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist. Am J Obstet Gynecol. 1986;154:1241-8.
17. Parr JH, Abraham RR, Seed M, Short F, Wynn V. The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LH RH agonist. J Endocrinol Invest. 1988;11:433-6.
18. Pascale MM, Pugeat M, Roberts M, Rousset H, Déchaud H, Dutrieux-Berger N, et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumors. Clin Endocrinol (Oxf). 1994;41:571-6.
19. Kaltsas GA, Mukherjee JJ, Kola B, Isidori AM, Hanson JA, Dacie JE, et al. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clin Endocrinol (Oxf). 2003;59:34-43.